Guanhao Biotech Co Ltd Cash Flow Conversion Efficiency
Guanhao Biotech Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Guanhao Biotech Co Ltd (300238) has a cash flow conversion efficiency ratio of 0.037x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥18.84 Million ≈ $2.76 Million USD) by net assets (CN¥506.03 Million ≈ $74.05 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Guanhao Biotech Co Ltd (2007–2025)
Cash flow conversion efficiency of Guanhao Biotech Co Ltd from 2007 to 2025. This chart illustrates how Guanhao Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Guanhao Biotech Co Ltd (300238) stock price for real-time trading data and today's change.
Guanhao Biotech Co Ltd Cash Flow Conversion Ratio Explained
Guanhao Biotech Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Guanhao Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guanhao Biotech Co Ltd ranked by their cash flow conversion efficiency. Also see market cap of Guanhao Biotech Co Ltd for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Fulgent Sun International Holding Co Ltd
TW:9802
|
-0.061x |
|
Shenzhen Jiang and Associates Creative Design Co Ltd
SHE:300668
|
0.019x |
|
Fujian Tendering Co. Ltd.
SHE:301136
|
N/A |
|
Borosil Limited
NSE:BOROLTD
|
0.059x |
|
Cambi ASA
OL:CAMBI
|
0.588x |
|
Mangalore Chemicals & Fertilizers Limited
NSE:MANGCHEFER
|
0.255x |
|
Kunshan Asia Aroma Corp. Ltd.
SHE:301220
|
0.002x |
|
PTG Energy PCL
BK:PTG
|
0.112x |
Annual Cash Flow Conversion Efficiency for Guanhao Biotech Co Ltd (2007–2025)
The table below shows the annual cash flow conversion efficiency of Guanhao Biotech Co Ltd from 2007 to 2025. Review free cash flow generation of Guanhao Biotech Co Ltd to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥506.03 Million ≈ $74.05 Million |
CN¥71.47 Million ≈ $10.46 Million |
0.141x | +33.28% |
| 2024-12-31 | CN¥467.59 Million ≈ $68.42 Million |
CN¥49.55 Million ≈ $7.25 Million |
0.106x | -10.70% |
| 2023-12-31 | CN¥456.26 Million ≈ $66.77 Million |
CN¥54.15 Million ≈ $7.92 Million |
0.119x | -27.96% |
| 2022-12-31 | CN¥430.88 Million ≈ $63.05 Million |
CN¥70.98 Million ≈ $10.39 Million |
0.165x | +0.70% |
| 2021-12-31 | CN¥748.16 Million ≈ $109.48 Million |
CN¥122.39 Million ≈ $17.91 Million |
0.164x | +12.91% |
| 2020-12-31 | CN¥716.66 Million ≈ $104.87 Million |
CN¥103.84 Million ≈ $15.19 Million |
0.145x | +10.24% |
| 2019-12-31 | CN¥704.14 Million ≈ $103.04 Million |
CN¥92.55 Million ≈ $13.54 Million |
0.131x | +370.53% |
| 2018-12-31 | CN¥1.16 Billion ≈ $169.08 Million |
CN¥32.28 Million ≈ $4.72 Million |
0.028x | +76.29% |
| 2017-12-31 | CN¥1.21 Billion ≈ $177.49 Million |
CN¥19.22 Million ≈ $2.81 Million |
0.016x | -24.74% |
| 2016-12-31 | CN¥1.46 Billion ≈ $213.26 Million |
CN¥30.68 Million ≈ $4.49 Million |
0.021x | -80.75% |
| 2015-12-31 | CN¥620.62 Million ≈ $90.82 Million |
CN¥67.87 Million ≈ $9.93 Million |
0.109x | -11.18% |
| 2014-12-31 | CN¥531.61 Million ≈ $77.79 Million |
CN¥65.45 Million ≈ $9.58 Million |
0.123x | +47.83% |
| 2013-12-31 | CN¥498.16 Million ≈ $72.90 Million |
CN¥41.49 Million ≈ $6.07 Million |
0.083x | -23.01% |
| 2012-12-31 | CN¥454.11 Million ≈ $66.45 Million |
CN¥49.12 Million ≈ $7.19 Million |
0.108x | +32.06% |
| 2011-12-31 | CN¥432.79 Million ≈ $63.33 Million |
CN¥35.45 Million ≈ $5.19 Million |
0.082x | -64.81% |
| 2010-12-31 | CN¥144.99 Million ≈ $21.22 Million |
CN¥33.76 Million ≈ $4.94 Million |
0.233x | +222.72% |
| 2009-12-31 | CN¥76.95 Million ≈ $11.26 Million |
CN¥5.55 Million ≈ $812.33K |
0.072x | -44.41% |
| 2008-12-31 | CN¥37.01 Million ≈ $5.42 Million |
CN¥4.80 Million ≈ $702.80K |
0.130x | +55.21% |
| 2007-12-31 | CN¥20.67 Million ≈ $3.02 Million |
CN¥1.73 Million ≈ $252.86K |
0.084x | -- |
About Guanhao Biotech Co Ltd
Guanhao Biotech Co.,Ltd. develops, manufactures, and sells regenerative medicines and life sciences products in China. It offers NormalGEN and GrandNeuro, both a dura repair patch; ThormalGEN, a surgical patch; DermalGEN, a wound dressing product; IREAL breast patch; and Youvision corneal graft, as well as license in intraocular lenses. The company also provides Biological dura, a spinal patch; T… Read more